MIRA Pharmaceuticals, Inc.(MIRA)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-11-27 | Aminov Erez Chief Executive Officer | Sale | -100,000 | -8.61%1,061,200 | $1.34 | $133,649 | View SEC filing | |
| 2024-08-30 | Bay Shore Trust 10% Owner | Sale | -200,000 | -7.30%2,540,270 | $1.96 | $392,000 | View SEC filing | |
| 2024-05-22 | Aminov Erez Chief Executive Officer | Purchase | +8,700 | +2.33%382,200 | $0.94 | $8,176 | View SEC filing | |
| 2023-12-27 | Bay Shore Trust 10% Owner | Sale | -238,095 | -76.92%660,000 | $3.05 | $726,088 | View SEC filing | |
| 2023-08-24 | Cappy George 10% Owner | Purchase | +119,048 | +4.34%2,859,318 | $7.00 | $833,336 | View SEC filing | |
| 2023-08-04 | Cappy George 10% Owner | Purchase | +157,170 | +6.08%2,740,270 | $7.00 | $1,100,190 | View SEC filing |
1-6 of 6